Fundraising FoxKdT Ventures — 2022 Investments
3 investments dated 2022 · listed companies and verified rows first · show all
Particella, Inc. (formerly DNAlite Therapeutics) is a preclinical biotechnology company developing an oral lipid nanoparticle platform to deliver nucleic acids, such as mRNA, to the intestinal epithelium.
BiotechDeep TechSan Francisco, US
Mubhij Ahmad(Executive Officer, Director)David Rabuka(Director)Timothy Paul Day(Director)
BoardDrew Lanza(Director)in
Board seatAndrew Cain McClary· per SEC Form D · $8.9M raise · filed Apr 2022
Co-investorsBerkeley CatalystBlue Bear Ventures
Durham, US
Kris Wood(Director)inEoin McDonnell(Executive Officer, Director)in
Co-investorsAlexandria
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.